Search results for: 'Hardware-In-The-Loop Market'
- Did you mean
- hardware in the lora market
- hardware in the long market
- Related search terms
- Hardware-in-the-Loop+
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- marketing strategy homes industry year 16.9
- marketing strateg homes industry year 1.09
- market analysi of rf energy harvesting technolog
-
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
21 Jul 2026  |  Global  |  Market Research
Point-of-Care Testing Market, Global, 2024–2031
The POCT Market is Experiencing Transformational Growth, Driven by Decentralized Molecular Diagnostics, Ultra-rapid Testing, and Connected Clinical Intelligence Ecosystems
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...
$2,450.00 -
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00 -
29 Aug 2025  |  Global  |  Market Research
Oncology Biomarker Diagnostics, Global, 2024–2030
Regulatory Approvals, Companion Diagnostic Partnerships, and Precision Medicine are Driving Transformational Growth in the Industry, Fueled by Advances in Genomic Profiling and AI Integration
This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...
$4,950.00 -
29 Aug 2025  |  Global  |  Customer Research
Laboratory Product Purchasing Trends in the United States and Europe, 2024–2025
An End-User Perspective on Spending and Growth Opportunities
Qualified respondents to this Frost & Sullivan survey were invited to participate in a telephone interview examining their laboratory’s product purchasing process in 2024 and expectations for 2025. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The survey provides companies with actionable and trendin...
$4,950.00 -
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
14 Feb 2025  |  Global  |  Market Research
Proteomics Research Tools and Diagnostics Market, Global, 2024-2030
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing...
$4,950.00
Special Price $4,455.00 save 10 %
-
16 Dec 2025  |  Europe  |  Market Outlook
Top 10 Growth Opportunities in the European Life Sciences Industry, 2026
Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience
Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...
$2,450.00 -
09 May 2025  |  Global  |  Technology Research
Emerging Anti-aging strategies
Evolving Anti-aging Strategies Are Driving Transformational Growth in Innovation, Market Players, and Emerging Opportunities
This report delves into the rapidly evolving anti-aging industry, highlighting the breakthrough innovations in cellular and genomic rejuvenation as well as AI/ML-driven anti-aging strategies. It explores the industry ecosystem, covering key players, emerging players, and academic researchers transforming the field. The analysis includes major techn...
$4,950.00
Special Price $4,455.00 save 10 %
-
08 Jul 2026  |  Global  |  Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
Emerging Innovations Driving Personalized and Effective Obesity Solutions
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...
$4,950.00